ロード中...
Evidence review of hydroxyurea for the prevention of sickle cell complications in low-income countries
Hydroxyurea is widely used in high-income countries for the management of sickle cell disease (SCD) in children. In Kenyan clinical guidelines, hydroxyurea is only recommended for adults with SCD. Yet many deaths from SCD occur in early childhood, deaths that might be prevented by an effective, dise...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMJ Publishing Group
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3812872/ https://ncbi.nlm.nih.gov/pubmed/23995076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/archdischild-2012-302387 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|